InvestSMART

Percheron Therapeutics Limited (ASX:PER)

ALERT: Price-sensitive ASX Announcement for PER
Current share price for PER : $0.004 -0.003 (-42.86%)+
Announcement
Release
16 Mar 2026 10:01AM
Price at Release
$0.007
Full Release
download
Summary
Percheron Therapeutics Limited's prospectus announces a non-renounceable entitlement offer to raise approximately $2.2 million. Eligible shareholders will be able to purchase new shares at a discounted price, with additional options available. The raised funds are intended for the development of the company's leading asset, HMBD-002, and general working capital. The offer, which is scheduled to close on April 8, 2026, is available to shareholders in select countries and is non-renounceable, meaning entitlements cannot be sold or transferred.
Key Points
  • Percheron Therapeutics Limited is issuing a Prospectus for a non-renounceable entitlement offer.
  • The offer is aimed at raising approximately $2.2 million.
  • The entitlement offer allows eligible shareholders to buy two new shares for every five shares they currently hold, at a price of $0.005 per new share.
  • Shareholders will also receive one new option for every two new shares subscribed, which can be exercised at $0.01 each.
  • The funds raised will progress the development of HMBD-002 and for general working capital.
  • The offer is open to eligible shareholders in Australia, New Zealand, Singapore, Hong Kong, and the United Kingdom.
  • The offer is scheduled to close on 8 April 2026.
  • The company's board and management hold significant shares and options in the company.
  • The entitlement is non-renounceable, meaning shareholders cannot sell their entitlements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.